Table 1 Schedule of assessments
From: A randomized, open-label, multicentre, comparative study of therapeutic efficacy, safety, and tolerability of BNO 1030 extract, containing marshmallow root, chamomile flowers, horsetail herb, walnut leaves, yarrow herb, oak bark, dandelion herb, in the treatment of mild forms of COVID-19
V1 | V2 | V3 |
|---|
day 1 | day 2 | day 3 | day 4 | day 5 | day 6 | day 7 | day 8 | day 9 | day 10 | day 11 | day 12 | day 13 | day 14 |
|---|
Treatment group |
Reference treatment + Imupret |
Control group |
Reference treatment |
- V1 day 1 Screening, randomization, prescription of treatment
- V2 day 4 ±1 phone contact /or virtual contact— clarification of the patient’s condition, need for an unscheduled visit
- V3 day 14 ±1 Evaluation of treatment efficacy, end of treatment
